Zacks Small Cap Research on MSN

YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
STAT

Watch: At JPM, former drug regulator Richard Pazdur rings the alarm about politics at FDA

Here's full footage from a STAT event with former top FDA official Richard Pazdur, who expressed grave concern about ...

Fortress Biotech, Inc.: Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO (copper histidinate), the First and Only Approved Treatment for Menkes ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...